Trial Identifier: | D6402C00009 |
Sponsor: | AstraZeneca |
Collaborator: |
Parexel
|
Start Date: | May 2025 |
Primary Completion Date: | July 2025 |
Study Completion Date: | August 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
GB | Harrow, GB, HA1 3UJ |